Option chain shows key data for Icecure Medical's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Icecure Medical.

Icecure Medical (NASDAQ:ICCM) Stock, Option Chain

Icecure Medical

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMCX

BIMI

BJDX

FLFV

ICCM

KAVL

LRHC

NDRA

NRIX

OVID

SCNI

SVMH

TRNR

VERO

XTLB

ZAPP

Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Earnings

Earnings Misses

Penny Stocks

Health Care

Analyst Ratings

General

The Oncology Institute, Inc. (NASDAQ: TOI) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.

The Oncology Institute, Inc. Reports Q1 Loss, Lags Revenue Estimates

Screenshot 2024-04-26 at 8.22.23 AM

Biotech

New Standard of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy

Icecure Medical Ltd

Wyoming Republican Senator Cynthia Lummis (R-Wyo.) on Thursday proposed converting Federal Reserve-held gold certificates into Bitcoin to establish <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42080839/cynthia-lummis-says-strategic-bitcoin-reserve-could-take-shape-soon-after-trump-raises-his-hand-and-is-sworn-in">a 20-year strategic</a> Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve.
In an <a href="https://www.youtube.com/watch?v=xSKRwaK4Lq4">interview</a> with CNBC, Lummis outlined how this initiative could bolster the US economy, reduce national debt and position Bitcoin as a key asset for the country.
<h3 class="wp-block-heading">Gold-To-Bitcoin Conversion: A Debt-Free Solution</h3>
Lummis stressed that the proposal wouldn't require new taxpayer dollars. 
Instead, the government could leverage its existing resources, particularly gold certificates held at the Federal Reserve's 12 banks. 
These certificates, currently valued at 1970s prices, could be updated to reflect their fair market value, sold and reinvested into Bitcoin.
"We wouldn't have to spend any new dollars," she explained, pointing out that the United States already holds over 200,000 Bitcoin in asset forfeiture funds, which could act as a foundational reserve. 
Lummis also emphasized the fiscal prudence of the strategy: "This would be an asset that could help shore up the US dollar as the world reserve currency."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42116475/paying-6-24-million-for-a-duct-taped-banana-justin-sun-did-just-that-and-now-hell-eat-it-as-part-of-this-unique-artistic-experience">Paying $6.24 Million For A Duct-Taped Banana? Justin Sun Did Just That — And Now He&#8217;ll Eat It &#8216;As Part Of This Unique Artistic Experience&#8217;</a>
<h3 class="wp-block-heading">The Case For A Strategic Bitcoin Reserve</h3>
Highlighting Bitcoin&#8217;s unique properties, Lummis described it as immutable, easily stored, and a hedge against inflation. 
She believes a strategic Bitcoin reserve could mitigate inflation&#8217;s effects, provide financial stability and potentially strengthen the US dollar's global standing.
"American people are still hurting from inflation, from high prices, and they want the national debt reduced," Lummis said. "These are ways to do it with an asset that is immutable and can easily be held by the federal government in a variety of vaults."
Lummis compared the proposal to the historical gold standard, noting its relevance in today's digital age. "We got off the gold standard a long time ago, but this would be a way to create a reserve for the future," she said.
<h3 class="wp-block-heading">Addressing Ethical Concerns</h3>
When asked about potential conflicts of interest, given the growing adoption of Bitcoin among policymakers, Lummis argued for transparency and fairness. 
She revealed that her personal Bitcoin holdings are in a blind trust, ensuring her ability to advocate for the cryptocurrency without bias.
"Bitcoin is legal tender in another country. We need to recognize that as Americans," she stated. 
Lummis compared Bitcoin ownership to commodities like cattle, noting that ethical ownership policies can coexist with advocacy. 
"Quite frankly, I believe it should be okay for people to own Bitcoin without doing what I did and putting it in a blind trust."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42114875/coinbase-ceo-brian-armstrong-stands-out-as-candidate-for-donald-trumps-reported-crypto-czar-position-cardano-co-founder-says">Coinbase CEO Brian Armstrong &#8216;Stands Out&#8217; As Candidate For Donald Trump&#8217;s Reported &#8216;Crypto Czar&#8217; Position, Cardano Co-Founder Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Strategic Bitcoin Reserve Wouldn't Require New Taxpayer Dollars, Says Sen. Cynthia Lummis

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>William Blair analyst Dylan Carden downgraded the rating for Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) from Outperform to Market Perform. Ulta Beauty shares closed at $343.26 on Wednesday. <a href="https://www.benzinga.com/quote/ULTA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e331a5064ed0001730315/ronald-epstein">B of A Securities analyst Ronald Epstein</a> downgraded RBC Bearings Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) from Buy to Neutral but raised the price target from $330 to $335. RBC Bearings shares closed at $324.46 on Wednesday. <a href="https://www.benzinga.com/quote/RBC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Janney Montgomery Scott analyst Robert Farnam downgraded The Hartford Financial Services Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) from Buy to Neutral and announced a $176 price target. Hanover Insurance shares closed at $118.21 on Wednesday. <a href="https://www.benzinga.com/quote/THG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>China Renaissance analyst Yiwen Zhang downgraded the rating for Grab Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) from Buy to Hold and announced a $5.4 price target. Grab Holdings shares closed at $5.66 on Wednesday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities analyst John Murphy downgraded Adient plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) from Buy to Neutral and lowered the price target from $30 to $24. Adient shares closed at $19.06 on Wednesday. <a href="https://www.benzinga.com/quote/ADNT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ULTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="553" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-1024x553.png" alt="" class="wp-image-659562" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-1024x553.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-768x415.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225.png 1215w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42114009/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields</a></li>
</ul>

Downgrades

Intraday Update

ADNT

GRAB

ULTA

This Ulta Beauty Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

TJX Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) reported better-than-expected earnings for its third <a href="https://finance.yahoo.com/news/tjx-companies-q3-earnings-revenue-140011671.html">quarter on Wednesday</a>.
The company reported third-quarter earnings per share of $1.14 (+11%), beating the street view of $1.09. Quarterly sales of $14.06 billion (+6%) beat the analyst consensus estimate of $13.95 billion.
TJX Companies reported a 3% increase in consolidated comparable store sales at the high end of the company's plan, driven entirely by higher customer transactions.
"I want to specifically highlight our European team for their strong results, which drove the 7% comp increase at our TJX International division," said Ernie Herrman, Chief Executive Officer and President of The TJX Companies.
TJX Companies expects fourth-quarter GAAP EPS to be between $1.12 and $1.14, below the consensus estimate of $1.17. For the fourth quarter, the company continues to expect consolidated comparable store sales to be up 2% to 3%.
For FY25, the company revised its GAAP EPS forecast to $4.15 – $4.17, slightly above the prior guidance of $4.09 – $4.13 and in line with the consensus of $4.16. For the full year fiscal 2025, the company continues to expect consolidated comparable store sales to be up 3%
TJX shares fell 0.5% to trade at $119.20 on Thursday.
These analysts made changes to their price targets on TJX following earnings announcement.
<ul>
<li>Deutsche Bank analyst Gabriella Carbone maintained TJX with a Buy and raised the price target from $130 to $131.</li>
<li>Evercore ISI Group analyst Michael Binetti maintained TJX with an Outperform rating and raised the price target from $138 to $142.</li>
<li>Telsey Advisory Group analyst Dana Telsey maintained the stock with an Outperform rating and maintained a $134 price target.</li>
</ul>
Considering buying TJX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="545" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140911/image-228-1024x545.png" alt="" class="wp-image-659631" style="width:684px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140911/image-228-1024x545.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140911/image-228-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140911/image-228-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140911/image-228.png 1250w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42117130/this-palo-alto-networks-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday">This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday</a></li>
</ul>

Price Target

TJX Analysts Increase Their Forecasts After Upbeat Earnings

Baldur&#8217;s Gate 3 is showing no signs of slowing down, with more players jumping into the<a href="https://www.benzinga.com/general/gaming"> game than ever. </a>
According to Michael Douse, Larian Studios' director of publishing, the game's average daily peak concurrent players are up 3% compared to last year, while average daily active users have increased by 20%.
See Also: <a href="https://www.benzinga.com/general/gaming/24/11/42093704/starfield-reaches-15-million-players-with-updates-new-content">Starfield Reaches 15 Million Players With Updates, New Content</a>
"If you zoom out on our sales chart, it looks like the heartbeat of a happy little guy," Douse shared on social media platform X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I am also happy to announce we have achieved 1 (one) more sale in The Holy See, the Vatican itself. Thank you Mr Pope and enjoy the game.
&mdash; Very AFK (@Cromwelp) <a href="https://twitter.com/Cromwelp/status/1858534543206347137?ref_src=twsrc%5Etfw">November 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">Modding Fuels The Game's Continued Success</h3>
Part of the game's staying power is its modding community. Since Tencent Holdings ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>) backed Larian added official mod support with Patch 7, fans have downloaded over 50 million mods. Some mods have even brought humor to the table, with 10,000 downloads dedicated to renaming Withers, the game's undead NPC, to "Bone Daddy."
Douse described the mods as "very good," reflecting how they continue to attract and engage players. Larian's CEO, Swen Vincke, previously called mod support a way for players to take over and expand the game's world.
<h3 class="wp-block-heading">What's Next For Larian Studios</h3>
While Baldur's Gate 3 remains a hit, Larian is already working on its next projects. The studio <a href="https://www.benzinga.com/general/gaming/24/03/37882963/sad-news-for-baldurs-gate-3-fans-larian-studios-ends-downloadable-content-sequel-plans-moves-beyon">briefly considered Baldur's Gate 4 </a>but decided to explore something new. 
<a href="https://www.benzinga.com/general/gaming/24/05/38938485/larian-studios-creator-of-baldurs-gate-3-launches-seventh-studio-for-very-ambitious-rpgs">Two games are currently in development</a>, both based on original ideas. Larian has teased these as the studio's "best work ever," though details remain secret for now.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42068231/sony-in-talks-to-acquire-elden-ring-publisher-kadokawa-report">Sony In Talks To Acquire Elden Ring Publisher Kadokawa: Report</a></li>
</ul>
Image courtesy: Larian Studios.

Gaming

TCEHY

Baldur's Gate 3 Sees More Players In 2024 Than During Launch Year: Here's Why

Deep-pocketed investors have adopted a bearish approach towards Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in THC usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Tenet Healthcare. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 36% leaning bullish and 54% bearish. Among these notable options, 2 are puts, totaling $50,501, and 9 are calls, amounting to $2,559,675.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $170.0 for Tenet Healthcare over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tenet Healthcare's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tenet Healthcare's whale activity within a strike price range from $80.0 to $170.0 in the last 30 days. 
<h3>Tenet Healthcare Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732216007_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$80.00</td>
<td>$550.8K</td>
<td align="right">8</td>
<td align="right">270</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$68.1</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$80.00</td>
<td>$530.4K</td>
<td align="right">8</td>
<td align="right">288</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$67.1</td>
<td>$67.1</td>
<td>$67.1</td>
<td>$80.00</td>
<td>$503.2K</td>
<td align="right">8</td>
<td align="right">96</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$67.7</td>
<td>$67.6</td>
<td>$67.6</td>
<td>$80.00</td>
<td>$471.1K</td>
<td align="right">8</td>
<td align="right">186</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$68.1</td>
<td>$68.0</td>
<td>$68.0</td>
<td>$80.00</td>
<td>$122.4K</td>
<td align="right">8</td>
<td align="right">487</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Following our analysis of the options activities associated with Tenet Healthcare, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Tenet Healthcare</h3>
<ul>
<li>Currently trading with a volume of 1,180,448, the THC's price is down by -2.04%, now at $148.74. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
<h3>What The Experts Say On Tenet Healthcare</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $197.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Tenet Healthcare, maintaining a target price of $190. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Tenet Healthcare, which currently sits at a price target of $205. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Tenet Healthcare, which currently sits at a price target of $196. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Tenet Healthcare, targeting a price of $217. 
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Overweight rating on Tenet Healthcare, which currently sits at a price target of $177. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tenet Healthcare with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Check Out What Whales Are Doing With THC

Investors with a lot of money to spend have taken a bullish stance on Twilio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TWLO, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for Twilio.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 25%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $28,604, and 7, calls, for a total amount of $311,820.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $140.0 for Twilio during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Twilio's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Twilio's whale activity within a strike price range from $75.0 to $140.0 in the last 30 days. 
<h3>Twilio Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732216001_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TWLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$5.9</td>
<td>$5.7</td>
<td>$5.8</td>
<td>$140.00</td>
<td>$87.0K</td>
<td>0</td>
<td>150</td>
</tr>
<tr>
<td>TWLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$6.95</td>
<td>$5.75</td>
<td>$7.0</td>
<td>$110.00</td>
<td>$70.0K</td>
<td>1.5K</td>
<td>12</td>
</tr>
<tr>
<td>TWLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.02</td>
<td>$2.01</td>
<td>$2.02</td>
<td>$115.00</td>
<td>$40.4K</td>
<td>3.1K</td>
<td>414</td>
</tr>
<tr>
<td>TWLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$39.75</td>
<td>$39.15</td>
<td>$39.15</td>
<td>$75.00</td>
<td>$31.3K</td>
<td>20</td>
<td>8</td>
</tr>
<tr>
<td>TWLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$7.3</td>
<td>$7.15</td>
<td>$7.15</td>
<td>$105.00</td>
<td>$28.6K</td>
<td>1.1K</td>
<td>1.1K</td>
</tr>
</tbody>
</table>

<h3>About Twilio</h3>
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
In light of the recent options history for Twilio, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Twilio Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,724,508, with TWLO's price up by 0.68%, positioned at $99.11.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 83 days.</li>
</ul>
<h3>Expert Opinions on Twilio</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $95.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Twilio, targeting a price of $94. 
&#x2A; Consistent in their evaluation, an analyst from Baird keeps a Neutral rating on Twilio with a target price of $80. 
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Twilio, maintaining a target price of $80. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Twilio, which currently sits at a price target of $90. 
&#x2A; In a positive move, an analyst from Monness, Crespi, Hardt has upgraded their rating to Buy and adjusted the price target to $135. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Twilio options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

TWLO

A Closer Look at Twilio's Options Market Dynamics

Investors with a lot of money to spend have taken a bullish stance on Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RIOT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Riot Platforms.
This isn't normal.
The overall sentiment of these big-money traders is split between 66% bullish and 8%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $254,409, and 8 are calls, for a total amount of $325,005.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $6.0 to $20.0 for Riot Platforms over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Riot Platforms's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Riot Platforms's significant trades, within a strike price range of $6.0 to $20.0, over the past month.
<h3>Riot Platforms 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732215996_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.35</td>
<td>$11.3</td>
<td>$11.3</td>
<td>$20.00</td>
<td>$133.3K</td>
<td>1.4K</td>
<td align="right">162</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.35</td>
<td>$4.2</td>
<td>$4.35</td>
<td>$17.00</td>
<td>$91.3K</td>
<td>5.9K</td>
<td align="right">285</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.13</td>
<td>$2.01</td>
<td>$2.01</td>
<td>$8.00</td>
<td>$50.2K</td>
<td>8.0K</td>
<td align="right">250</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.3</td>
<td>$3.2</td>
<td>$3.2</td>
<td>$10.00</td>
<td>$48.0K</td>
<td>11.6K</td>
<td align="right">432</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$1.62</td>
<td>$1.53</td>
<td>$1.63</td>
<td>$11.50</td>
<td>$44.8K</td>
<td>22</td>
<td align="right">287</td>
</tr>
</tbody>
</table>

<h3>About Riot Platforms</h3>
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.
In light of the recent options history for Riot Platforms, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Riot Platforms</h3>
<ul>
<li>With a trading volume of 43,553,048, the price of RIOT is down by -0.91%, reaching $12.04.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 91 days from now.</li>
</ul>
<h3>Expert Opinions on Riot Platforms</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $14.625.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $11. 
&#x2A; An analyst from HC Wainwright &amp; Co. has revised its rating downward to Buy, adjusting the price target to $17. 
&#x2A; An analyst from Compass Point has decided to maintain their Buy rating on Riot Platforms, which currently sits at a price target of $13. 
&#x2A; An analyst from Macquarie has decided to maintain their Outperform rating on Riot Platforms, which currently sits at a price target of $17. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Riot Platforms, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

RIOT

This Is What Whales Are Betting On Riot Platforms

Despite the stellar numbers in <a href="https://www.benzinga.com/24/11/42099904/nvidia-q3-earnings-highlights">its latest earnings report</a>, Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) stock slipped 3% in after-hours trading on Wednesday.
In premarket Thursday, Nvidia shares swung between gains and losses, ultimately opening 5% higher before losing steam.
By mid-morning, Nvidia shares were down 1.23%, trading at $144.10—a move many attribute to the priced-for-perfection environment surrounding the AI giant. It seems the market's insatiable appetite for upside surprises left even Nvidia's blockbuster results struggling to impress.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42119226/nvidia-analysts-see-stock-best-positioned-in-ai-not-worried-about-guidance-all-systems-go-for-blackwell-ramp">Nvidia Analysts See Stock &#8216;Best Positioned In AI,&#8217; Not Worried About Guidance: &#8216;All Systems Go For Blackwell Ramp&#8217;</a>
<h2 class="wp-block-heading">Nvidia Stock&#8217;s Underlying Resilience</h2>
The Santa Clara, California-based company reported an 8% beat on earnings per share and a nearly 6% revenue beat <a href="https://www.benzinga.com/quote/NVDA/earnings">compared to estimates</a>. Revenue soared 93.71% year-over-year, reaching $35.1 billion, fueled by the relentless demand for AI chips.
Despite Thursday&#8217;s volatile trading, Nvidia's technical indicators suggest underlying resilience.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="628" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21113433/Screenshot-2024-11-21-at-10.04.19-PM.png" alt="" class="wp-image-659262" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21113433/Screenshot-2024-11-21-at-10.04.19-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21113433/Screenshot-2024-11-21-at-10.04.19-PM-300x234.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Read Also: <a href="https://www.benzinga.com/24/11/42107863/us-futures-head-lower-as-nvidia-reports-slowdown-in-quarterly-revenue-growth-expert-says-market-weakness-is-perfectly-normal-but-late-november-is-still-possible">US Futures Head Lower As Nvidia Earnings Fail To Impress Investors: Expert Says Market Weakness Is &#8216;Perfectly Normal,&#8217; But Late November Rally Is Still Possible</a>
The stock is trading above its eight-day, 20-day, 50-day and 200-day simple moving averages, signaling a strong bullish foundation:
<ul>
<li>8-day SMA: Nvidia sits at $145.29, above its $145.20 SMA, generating a short-term bullish signal.</li>
<li>20-day SMA: The stock's $145.29 price exceeds the $142.79 average, reinforcing the bullish narrative.</li>
<li>50-day SMA: Nvidia's $145.29 eclipses its 50-day average of $133.52, pointing to solid momentum.</li>
<li>200-day SMA: At $110.41, the 200-day average remains far below current levels, reflecting long-term bullish strength.</li>
</ul>
The MACD (moving average convergence/divergence) indicator also supports a bullish outlook with a reading of 3.19, while the RSI (relative strength index) at 56.51 shows the stock is comfortably neutral, leaving room for further upward movement without triggering overbought alarms.
<h2 class="wp-block-heading">Can Nvidia Break Free?</h2>
Nvidia's fundamentals remain as robust as its AI ambitions, but the question lingers: Can the stock sustain its high-altitude trajectory amid sky-high expectations? 
Investors will be watching closely as Nvidia tries to stabilize after its earnings-induced turbulence.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42107674/nvidia-vs-bitcoin-jensen-huang-led-chip-giants-stock-outperformed-the-top-cryptocurrency-over-5-years-heres-how-they-compare-on-other-metrics">Nvidia Vs. Bitcoin: Jensen Huang-Led Chip Giant&#8217;s Stock Outperformed The Top Cryptocurrency Over 5 Years. Here&#8217;s How They Compare On Other Metrics</a></li>
</ul>
Image: Unsplash

Earnings Beats

Technicals

Tech

NVDA

Nvidia's Post-Earnings Jitters: Can NVDA Stock Regain Its AI-Fueled Momentum?

<a href="https://www.nytimes.com/2024/11/21/business/trump-media-crypto-payment-service.html">https://www.nytimes.com/2024/11/21/business/trump-media-crypto-payment-service.html</a>
Donald J. Trump's social media company is considering developing a cryptocurrency payment service, according to a trademark application filed this week, the latest sign of the president-elect's embrace of the crypto industry.
Trump Media &amp; Technology Group <a href="https://tsdr.uspto.gov/#caseNumber=98859006&amp;caseSearchType=US_APPLICATION&amp;caseType=DEFAULT&amp;searchType=statusSearch">filed an application on Monday</a> for a service called TruthFi, which it described as a platform for crypto payments, financial custody services and trading in digital assets.
The application was light on details about how the project would work or how close it was to fruition. But the initiative appears to be a bid by Trump Media to diversify its business beyond Truth Social, a social media platform whose business relies on Mr. Trump to continuously post messages to his most loyal supporters.
Any large-scale crypto project would likely require Trump Media to acquire another firm, given that it has fewer than three dozen employees. This week, shares in the crypto trading platform Bakkt surged, after the Financial Times <a href="https://www.ft.com/content/d7f921d5-3668-4b6b-a98d-2681ad73610f">reported</a> that Trump Media was in talks to buy it.
&nbsp;
Trump Media did not immediately respond to a request for comment. Bakkt, which is losing money, <a href="https://investors.bakkt.com/news/news-details/2024/Bakkt-Statement-on-Transaction-Rumors/default.aspx">put out a statement</a> on Tuesday saying it does not comment on market speculation or rumors.
Josh Gerben, a Washington D.C.-based trademark lawyer, said that the filing is a way for Trump Media to reserve the TruthFi name if it goes forward with a crypto business. He said that companies can usually reserve a name for as long as a few years. But companies typically file a trademark application with the intent to use it.
"In my experience, most of the time if a client is going to file an application, there is something going on," Mr. Gerben said.
Trump Media is currently valued at around $6.5 billion, despite taking in just over <a href="https://www.nytimes.com/2024/11/06/business/trump-media-stock-price.html">$1 million in revenue</a> in the third quarter — all of it from advertising on Truth Social. With Truth Social struggling to gain new users and advertising despite Mr. Trump's popularity, Trump Media needs new businesses to bolster its revenue.
Mr. Trump has no formal role in the company that bears his name, but he owns nearly 53 percent of Trump Media's stock, and that stake — valued at $3.4 billion — is his most valuable asset. His eldest son, Donald Jr., is a member of Trump Media's board, which is stocked with loyalists to the president-elect.

Bakkt Holdings, Inc. Class A Common Stock

BKKT

'Trump Media May Be Mulling A Crypto Payment Service; The Parent Company Of Truth Social Filed A Trademark Application For A Crypto Payment Service It Called TruthFi' - NY Times

Universal Technical Institute, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) reported better-than-expected earnings for its fourth <a href="https://www.benzinga.com/quote/UTI/earnings">quarter on Wednesday</a>.
The company posted quarterly earnings of 34 cents per share which beat the analyst consensus estimate of 30 cents per share. The company reported quarterly sales of $196.36 million which beat the analyst consensus estimate of $191.39 million.
&#8220;We concluded the first stage of our North Star Strategy in fiscal 2024 achieving both strong results and momentum,&#8221; said Jerome Grant, CEO of Universal Technical Institute, Inc. &#8220;We met or exceeded guidance across all key metrics with full year revenue and adjusted EBITDA increasing over 21% and 60% year-over-year, respectively. These results reflect our consistent execution on the growth, diversification, and optimization tenets of our strategic plan as we continue ramping newly launched programs across both divisions, while further improving margins through workforce and facilities optimization.
Universal Technical Institute said it sees FY25 earnings of 93 cents to $1.01 per share on revenue of $800 million to $815 million.
Universal Technical Institute shares jumped 20.3% to trade at $23.92 on Thursday.
These analysts made changes to their price targets on Universal Technical Institute following earnings announcement.
<ul>
<li>Lake Street analyst Eric Martinuzzi maintained Universal Technical with a Buy and raised the price target from $19 to $22.</li>
<li>Barrington Research analyst Alexander Paris maintained the stock with an Outperform rating and raised the price target from $22 to $25.</li>
<li>Truist Securities analyst Jasper Bibb maintained Universal Technical with a Buy and raised the price target from $22 to $26.</li>
</ul>
Considering buying UTI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140124/image-227-1024x535.png" alt="" class="wp-image-659612" style="width:706px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140124/image-227-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140124/image-227-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140124/image-227-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21140124/image-227.png 1192w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42117130/this-palo-alto-networks-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday">This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday</a></li>
</ul>

These Analysts Increase Their Forecasts On Universal Technical Institute After Strong Earnings

<a href="https://www.ft.com/content/c61e57aa-3f63-40fa-853a-cfc0eeffc7b0" title="https://www.ft.com/content/c61e57aa-3f63-40fa-853a-cfc0eeffc7b0">https://www.ft.com/content/c61e57aa-3f63-40fa-853a-cfc0eeffc7b0</a>

Management

Global

'Three Bank Of America Bankers In India Depart Over Alleged Client Tips' - Financial Times

Wall Street witnessed a positive momentum on Thursday as investor risk appetite remained resilient despite escalating geopolitical tensions in Europe. The market brushed off concerns following a Russian missile strike on a Ukrainian military facility overnight, which came in response to Ukrainian missile <a href="https://www.benzinga.com/24/11/42113449/natural-gas-prices-spike-to-over-1-year-highs-oil-surges-to-70-as-russia-fires-intercontinental-ballistic-missile-to-ukraine">attacks earlier this week. </a>
Russian President Vladimir Putin, in a televised address on Thursday, stated that after the use of long-range missiles from Ukraine, &#8220;the regional conflict gained elements of global one.&#8221;
Major U.S. indices traded higher by midday trading in New York, with standout performances among blue-chip stocks and small-cap equities. 
The Dow Jones Industrial Average surged 500 points, reaching 43,965, marking a 1.3% gain and its strongest session in over two weeks.
The Russell 2000 outperformed with a 1.7% jump, setting up its best day since the post-election rally. 
In contrast, the Nasdaq 100 lagged slightly, rising 0.5%. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), despite higher-than-expected earnings, failed to spark broader optimism in the tech sector. Meanwhile, shares of Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) tumbled nearly 6% after the Department of Justice (DOJ) mandated the sale of Google Chrome aimed at curbing Google&#8217;s dominant position in search and digital advertising.
Geopolitical uncertainties drove strong gains in the commodities market. <a href="https://www.benzinga.com/news/global/24/11/42118286/7-us-natural-gas-stocks-to-watch-as-henry-hub-prices-surge-50-in-november">Natural gas Henry Hub prices </a>soared 5%, bringing year-to-date gains to over 50% and marking the best monthly performance since July 2022. Crude oil prices also climbed 0.9%, supported by supply concerns.
Gold extended its winning streak, rising 0.7% for its fourth consecutive session of gains as investors sought safe-haven assets.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) continued its rally, rising over 3% and hitting an intraday high of $98,367. The largest cryptocurrency now hovers tantalizingly close to the $100,000 milestone. 
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,365.25</td>
<td>1.7%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,965.39</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,949.37</td>
<td>0.5%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,739.86</td>
<td>0.4%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent111924&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.6% to $593.78.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;rose 1.3% to $439.81.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.3% to $504.89.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) soared 1.7% to $234.91.</li>
<li>The&nbsp;Financial Sector Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) outperformed, rising 1.6%. The&nbsp;Communication Services Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) lagged, down 0.5%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul>
<li>Nvidia Corp. fell 0.6% despite surpassing Street&#8217;s consensus estimates on both earnings per share and revenue during the third quarter. Analysts have raised price targets with Wedbush at $175, Baird at $195 and Barclays at $160.</li>
<li>Despite the dismal reaction by Nvidia, semiconductor stocks, as tracked by the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) rose 1.9%. Major gainers on Thursday were Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), up 4.7%; Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), up 3.9% and Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), up 3.7%.</li>
<li>PDD Holdings Inc. &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) tumbled nearly 10% after missing earnings and revenue estimates.</li>
<li>Other stocks reacting to earnings included Deere &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), up 8.8%; Warner Music Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>), down 8%; Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>), up 1.4% and Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), up 32%.</li>
<li>Companies slated to report their earnings after the close include Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), Copart Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>), Ross Stores Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROSS#NASDAQ">ROSS</a>) and NetApp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>). </li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42118286/7-us-natural-gas-stocks-to-watch-as-henry-hub-prices-surge-50-in-november">7 US Natural Gas Stocks To Watch As Henry Hub Prices Surge 50% In November</a></li>
</ul>
Photo: Shutterstock

Large Cap

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Specialty ETFs

Eurozone

Commodities

Small Cap

Economics

ETFs

AMAT

CPRT

SPDR Dow Jones Industrial Average ETF Trust

GOOG

GOOGL

INTU

MRVL

NTAP

PANW

Citigourp Global Markets 2% Protected Notes Linked To The Djia

ROSS

SNOW

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Small Caps Rally, Alphabet Plummets, Bitcoin Flirts With $100,000: What's Driving Markets Thursday?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Truist Securities boosted the price target for Universal Technical Institute, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) from $22 to $26. Truist Securities analyst Jasper Bibb maintained a Buy rating. Universal Technical Institute shares closed at $19.89 on Wednesday. <a href="https://www.benzinga.com/quote/UTI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel increased the price target for Digital Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) from $195 to $205. Stifel analyst Erik Rasmussen maintained a Buy rating. Digital Realty Trust shares closed at $185.91 on Wednesday. <a href="https://www.benzinga.com/quote/DLR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities raised Wix.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) price target from $190 to $220. B. Riley Securities analyst Naved Khan maintained a Buy rating. Wix.com shares settled at $210.27 on Wednesday. <a href="https://www.benzinga.com/quote/WIX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo boosted Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) price target from $140 to $165. Wells Fargo analyst Zachary Fadem maintained an Equal-Weight rating. Williams-Sonoma shares closed at $175.04 on Wednesday. <a href="https://www.benzinga.com/quote/WSM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Rosenblatt increased NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) price target from $200 to $220. Rosenblatt analyst Hans Mosesmann maintained a Buy rating. Nvidia shares closed at $145.89 on Wednesday.  <a href="https://www.benzinga.com/quote/NVDA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS boosted Spire Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) price target from $75 to $80. UBS analyst William Appicelli maintained a Buy rating. Spire shares closed at $68.39 on Wednesday. See how other analysts view this stock.</li>
<li>Guggenheim cut the price target for AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) from $190 to $189. Guggenheim analyst Ali Faghri maintained a Buy rating. AutoNation shares settled at $164.85 on Wednesday. <a href="https://www.benzinga.com/quote/AN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen boosted Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) price target from $290 to $340. TD Cowen analyst J. Derrick Wood maintained a Hold rating. Salesforce shares closed at $325.70 on Wednesday. <a href="https://www.benzinga.com/quote/CRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group increased the price target for The TJX Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) from $138 to $142. Evercore ISI Group analyst Michael Binetti maintained an Outperform rating. TJX shares closed at $119.74 on Wednesday. <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank boosted Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) price target from $180 to $190. Deutsche Bank analyst Brad Zelnick maintained a Buy rating. Snowflake shares closed at $129.12 on Wednesday. <a href="https://www.benzinga.com/quote/snow/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NVDA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="549" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-1024x549.png" alt="" class="wp-image-659589" style="width:718px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-1024x549.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-768x412.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226.png 1242w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42119232/ross-stores-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Ross Stores Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Nvidia To Rally More Than 50%? Here Are 10 Top Analyst Forecasts For Thursday

Legal

U.S. Justice Department Seeks To Unwind Google's Anthropic Deal

Conduit Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares are trading higher Thursday after the company announced that the Japan Patent Office granted a composition of matter patent for its lead asset, AZD1656. Here&#8217;s <a href="https://www.benzinga.com/quote/CDT/news">what you need to know.</a>
What To Know: AZD1656 is a glucokinase activator designed to target a range of autoimmune disorders. The patent approval in Japan comes after a similar patent was granted in Australia, marking continued progress in securing intellectual property protections for the company&#8217;s assets.
&#8220;This approval represents another significant milestone in our efforts to maximize the value of our intellectual property portfolio,&#8221; said David Tapolczay, CEO of Conduit Pharmaceuticals.
See Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42119232/ross-stores-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Ross Stores Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>
 AZD1656 is part of Conduit&#8217;s strategy to address unmet medical needs, particularly in diseases like Lupus and ANCA Vasculitis. Conduit Pharmaceuticals is also working on other assets, including AZD5658 and AZD5904, to expand its portfolio in the autoimmune space.
&#8220;The granting of this patent in Japan, one of the world&#8217;s largest pharmaceutical markets, underscores the strength of our scientific and intellectual property strategy. We look forward to securing additional approvals in other major markets, further enhancing our global patent coverage and bolstering our out-licensing opportunities,&#8221; Tapolczay added.
CDT Price Action: Conduit Pharmaceuticals shares were up 20.4% at 11 cents at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="548" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-1024x548.png" alt="" class="wp-image-659391" style="width:434px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-1024x548.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-768x411.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT.png 1129w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42118680/elon-musk-promises-40-minute-flights-from-nyc-to-shanghai-will-prices-make-it-accessible-to-all">Elon Musk Promises 40-Minute Flights from NYC To Shanghai – Will Prices Make It Accessible To All?</a></li>
</ul>
Image Via Shutterstock.

What's Going On With Conduit Pharmaceuticals Shares Today?

Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) shares are trading higher on Thursday. The company&#8217;s shares may be moving higher in response to its acquisition target Atomic Alchemy which signed a Memorandum of Understanding (MOU) with Zeno Power. Here&#8217;s what you <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42092578/oklo-stock-slides-as-short-seller-sets-sights-on-altman-backed-nuclear-startup">need to know</a>.
What To Know: The goal of the MOU is for Atomic Alchemy to provide Zeno Power with radioisotopes like strontium-90 and americium-241 to power Zeno&#8217;s Radioisotope Power Systems (RPSs).
These systems generate energy from the heat emitted by radioisotopes, powering critical applications such as space exploration and national defense.
&#8220;We are thrilled to be working with Atomic Alchemy and Oklo to advance our fuel supply chain efforts and recover radioisotopes that otherwise would be waste,&#8221; said Harsh S. Desai, Chief Commercialization Officer at Zeno Power. 
&#8220;This partnership aims to expand access to critical isotopes, accelerating our work to meet the growing demand for reliable, persistent energy solutions from the ocean floor to the lunar surface.&#8221;
Previously, Oklo has proposed to acquire Atomic through an all-stock transaction. 
Related Link: <a href="https://www.benzinga.com/news/large-cap/24/11/42094649/nvidia-stock-historically-drops-in-december-after-q3-earnings">Nvidia Stock Historically Drops In December After Q3 Earnings</a>
OKLO Price Action: At the time of writing, Oklo shares are trading 15.8% higher at $24.27, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Courtesy of Oklo, Inc.

OKLO

What's Going On With Oklo Shares Thursday?

WIIM

BIDU

Baidu shares are trading lower. The company reported Q3 financial results.

Hewlett Packard shares are trading higher after RWE announced it will bolster its renewable energy with HPE's AI weather modeling.

Virgin Galactic Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) short percent of float has fallen 3.11% since its last report. The company recently reported that it has 6.90 million shares sold short, which is 23.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.42 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Virgin Galactic Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732214720_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Virgin Galactic Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Virgin Galactic Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Virgin Galactic Hldgs's peer group average for short interest as a percentage of float is 6.16%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

SPCE

(SPCE) - Analyzing Virgin Galactic Hldgs's Short Interest

CVS Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) short percent of float has risen 5.45% since its last report. The company recently reported that it has 21.85 million shares sold short, which is 1.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.75 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CVS Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732214715_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CVS Health has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing CVS Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CVS Health's peer group average for short interest as a percentage of float is 8.23%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(CVS) - Analyzing CVS Health's Short Interest

Icecure Medical (ICCM) has released an update. IceCure Medical's ProSense cryoablation technology, which destroys tumors by freezing, demonstrated ...

IceCure's ProSense Shows High Success in Tumor Treatment

Icecure Medical (ICCM) has released an update. IceCure Medical's ProSense&#xAE; Cryoablation system has demonstrated a 96.3% recurrence-free rate in ear...

IceCure Medical's ProSense® Shows Promising Trial Results

Icecure Medical (ICCM) has released an update. IceCure Medical's ProSense system showcased impressive results at the European Society of Breast Ima...

IceCure's ProSense Excels in Global Cryoablation Studies

Analyst Anthony Vendetti from Maxim Group reiterated a Buy rating on Icecure Medical (ICCM – Research Report) and keeping the price target at $3.00...

Icecure Medical: A Strong Buy on Clinical Success and Upcoming Regulatory Catalysts

IceCure Medical files to sell ordinary shares and warrants

IceCure Medical (ICCM) has received a Notice of Allowance for its invention titled "Cryogenic System Connector" from the USPTO. This is the first g...

IceCure Medical granted patent by USPTO for cryoablation system

Icecure Medical (ICCM) has released an update. IceCure Medical has received a Notice of Allowance from the U.S. Patent and Trademark Office for its...

IceCure Medical Expands Patent Portfolio with New US Approval

Icecure Medical (ICCM) has released an update. IceCure Medical has received a favorable recommendation from the FDA Advisory Panel for its ProSense...

IceCure Medical's ProSense® Gains FDA Panel Support

IceCure gets favorable FDA AdCom vote for ProSense System

Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Icecure Medical (ICCM – Research Report) yesterday and set a price target of $3.00....

Icecure Medical's ProSense System Gains Favorable FDA Panel Recommendation and Strong Financial Position Supports Buy Rating

Screenshot 2024-04-12 at 5.32.25 PM

Game-Changing Tumor Freezing Technology Has The Potential To Offer Women First-Ever Minimally Invasive Alternative To Breast Lumpectomy Surgery

Press Releases

IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets Conferences

IceCure Announces FDA Advisory Panel Meeting Date for Marketing Authorization of ProSense® in Early-Stage Low Risk Breast Cancer Scheduled for November 7, 2024

Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft Tissues

IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free Rate

IceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging Conference

IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System

Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders

FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer

IceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of Health

Comments

Icecure Medical

Icecure Medical (ICCM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga